Restore Medical

We are thrilled to announce that Restore Medical has received Breakthrough Device designation from the FDA for our innovative ContraBand™ system! This designation is based on the successful results of efficacy and safety from our ongoing feasibility study, marking a significant milestone in our mission to advance cardiac care for patients with Heart Failure with Reduced Ejection Fraction (HFrEF). A special thank you goes to our investors, principal investigators and the entire Restore Medical team for their dedication and hard work in making this achievement possible. Our investors: #EUeic, #eicAccelerator Peregrine Ventures, Our amazing team: Stephen Bellomo, Aida Bibliowicz, Elchanan Bruckheimer,Shira Hauser, Ori Kohn, Nerry Gavra, Efrat Tal, Rom Gefen, Naama Halvi, Aaron Feldman Our SAB and medical advisors: Shmuel Banai, Sean Pinney, Marty Leon, Offer Amir, Stefan Verheye, Elazer Edelman, Baylor Scott & White Health, Nir Flint, Marat Fudim Our PIs: Gediminas Rackauskas, Edgard Prihadi, Petr Neuzil, Horst Sievert, , Vivek Reddy, Matthias Dupont, Piotr J. Wacinski, Jacob George https://lnkd.in/eyTk9MdY #hfref #chf

Very proud to have been present during the implantation in the 24th and 25th patient in Europe!!   Both patients were implanted with the ContraBand™ system, the first and only transcatheter Pulmonary Artery Banding (PAB) system for the treatment of HFrEF patients. The credit goes to Independent Public Clinical Hospital No. 4 in Lublin, Poland and their amazing team, lead by Prof. Piotr Wacinski, Dr. Pawel Binko and Dr. Andrzej Madejczyk. Thank you for the great professionalism and collaboration! Both patients had an uneventful procedure, and we hope to see their HF symptoms and their physical capacity improve in the next few months. This is just the beginning of our work in Poland, and we are looking forward to more cases together. ClinicalTrials.gov ID NCT05230745 - ContraBand™: FIH Safety & Feasibility Study (RM-20-01) #interventionalcardiology #PAB #medicaldevices #medtech

Thrilled and grateful to announce that Restore Medical has been awarded the runner-up position in the THT Shark Tank competition! This achievement underscores the groundbreaking results we presented on enhanced hemodynamics, LV reverse remodeling, and pronounced improvement in patients' physical capacity. Notably, our approach has demonstrated a strong safety profile over 24 months of follow-up. A heartfelt thank you to Dan Burkhoff, Marty Leon, and the entire THT committee for providing this incredible opportunity and recognizing the potential of our work. Special gratitude also extends to Prof. Sean Pinney for presenting the exciting results on exercised hemodynamics, and to the EIC, Eyal Lifschitz, Lior Shahory, and the entire Peregrine Ventures team for their continuous support on this remarkable journey. This accomplishment signifies a significant milestone for Restore Medical, and we are more inspired than ever to continue our mission of advancing the landscape of heart failure treatment. Thank you to everyone who has been part of our journey – your support is truly appreciated! #THTSharkTank #RestoreMedical #HeartFailureInnovation #EUeic, #eicAccelerator #hfref #chf #tht

Thrilled and grateful to announce that Restore Medical has been awarded the runner-up position in the THT Shark Tank competition! This achievement underscores the groundbreaking results we presented on enhanced hemodynamics, LV reverse remodeling, and pronounced improvement in patients' physical capacity. Notably, our approach has demonstrated a strong safety profile over 24 months of follow-up. A heartfelt thank you to Dan Burkhoff, Marty Leon, and the entire THT committee for providing this incredible opportunity and recognizing the potential of our work. Special gratitude also extends to Prof. Sean Pinney for presenting the exciting results on exercised hemodynamics, and to the EIC, Eyal Lifschitz, Lior Shahory, and the entire Peregrine Ventures team for their continuous support on this remarkable journey. This accomplishment signifies a significant milestone for Restore Medical, and we are more inspired than ever to continue our mission of advancing the landscape of heart failure treatment. Thank you to everyone who has been part of our journey – your support is truly appreciated! #THTSharkTank #RestoreMedical #HeartFailureInnovation #EUeic, #eicAccelerator #hfref #hemodynamics #chf #heartfailure #tht

Thank you Dr. Elchanan Bruckheimer for the enlightening talk at the THT Conference and for unveiling the remarkable LV Remodeling results from the ContraBand device clinical study. Kudos to Dr. Bruckheimer and the Restore Medical team for their groundbreaking work. #MedicalInnovation #THTConference #LVRemodeling #ContraBandTM

We are looking forward to participating in the Technologies and Heart Failure Therapeutics (THT) conference, where Restore Medical will be at the forefront with three exciting presentations: 1️⃣ Controlled Pulmonary Banding for Dilated Cardiomyopathy: The Restore Medical Approach presented by Dr. Elchanan Bruckheimer 🗓️ Monday, March 4th, 17:30 📍 Grand Ballroom C-E 2️⃣ Shark Tank Contest: Innovative Insights presented by our CEO Gilad Marom 🗓️ Tuesday, March 5th, 7:45AM 📍 Grand Ballroom C-E 3️⃣ Initial Results of Invasive Exercise Hemodynamics and Updates from Ongoing First-in-Human Trial presented by Prof. Sean Pinney 🗓️ Wednesday, March 6th, 7:15 AM 📍 Grand Ballroom C-E These sessions will unveil promising clinical results from our ongoing feasibility study, highlighting our commitment to advancing therapy for heart failure #RestoreMedical #THTConference #heartfailure #Innovation #eic